Neither Grail nor Fail-In Defense of Myocardial Cell Therapy: Reply. | Ann Thorac Surg;110(6): 2104-2105, 2020 12. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Neither Grail nor Fail-In Defense of Myocardial Cell Therapy: Reply.

Horvath, Keith A.

Affiliation

Horvath KA; Cardiothoracic Surgery Research Program, National Heart, Lung and Blood Institute, National Institutes of Health, 655 K St, NW #100, Washington, DC 20001. Electronic address: khorvath@aamc.org.

Ann Thorac Surg ; 110(6): 2104-2105, 2020 12.

Article in En | MEDLINE | ID: mdl-32504595

Subject(s)

Cell- and Tissue-Based Therapy; Myocytes, Cardiac; Bone Marrow Cells; Cell Proliferation; Humans; Patients

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myocytes, Cardiac / Cell- and Tissue-Based Therapy Limits: Humans Language: En Journal: Ann Thorac Surg Year: 2020 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myocytes, Cardiac / Cell- and Tissue-Based Therapy Limits: Humans Language: En Journal: Ann Thorac Surg Year: 2020 Document type: Article